SCHEMBL19341764

SCHEMBL19341764

CC(=O)C(N)Cc1ccc(I)cc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 3/20 0.51
▸ SLC7A5 Q01650 2/20 0.48
▸ ALPI P09923 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ XIAP P98170 1/20 0.47
▸ MMP2 P08253 1/20 0.47
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ APEX1 P27695 1/20 0.43
▸ PMP22 Q01453 1/20 0.43
▸ DPP7 Q9UHL4 1/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ CSK P41240 1/20 0.41
▸ TPH1 P17752 1/20 0.41
▸ GRB2 P62993 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL684698 1.00 DPP4 (0.51) DPP4SLC7A5ALPIPKMPTGS1
SCHEMBL17178041 1.00 DPP4 (0.51) DPP4SLC7A5ALPIPKMPTGS1
SCHEMBL290031 0.84 DPP4 (0.51) DPP4SLC7A5ALPIPKMPTGS1
SCHEMBL12028956 0.84 DPP4 (0.51) DPP4SLC7A5ALPIPKMPTGS1
Iodofalan SCHEMBL44619 0.84 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL290032 0.84 DPP4 (0.51) DPP4SLC7A5ALPIPKMPTGS1
Iodofalan SCHEMBL44618 0.84 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Iodofalan SCHEMBL44620 0.84 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL679800 0.83 DPP4 (0.48) DPP4SLC7A5ALPIPKMPTGS1
SCHEMBL17173866 0.83 DPP4 (0.48) DPP4SLC7A5ALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170258805-A1 INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE WISCONSIN ALUMNI RESEARCH FOUNDATION 2017-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170258805-A1 INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE UGDH, GALE, UGGT1 DPP4 360/4885SLC7A5 1362/4885ALPI 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback